First Life Sciences Fund established under the Enterprise Ireland Seed and Venture Capital Scheme 2007-2012; €75 million raised

	\| Click for the Finfacts Ireland Portal Homepage \| <script language="javascript" src="http://adserver.adtech.de/addyn\|3.0\|257\|1057011\|0\|1\|ADTECH;loc=700;target=_blank;key=key1+key2+key3+key4;grp=1054"></script><noscript><a href="http://adserver.adtech.de/adlink\|3.0\|257\|1057011\|0\|1\|ADTECH;loc=300;key=key1+key2+key3+key4;grp=1054" target="_blank"><img src="http://adserver.adtech.de/adserv\|3.0\|257\|1057011\|0\|1\|ADTECH;loc=300;key=key1+key2+key3+key4;grp=1054" border="0" width="468" height="60"></a></noscript>

Finfacts Business News Centre

Home


	News
	Irish
	European
	International

	Analysis/Comment

RSS FEED

How to use our RSS feed

See Search Box lower down this column for searches of Finfacts news pages. Where there may be the odd special character missing from an older page, it's a problem that developed when Interactive Tools upgraded to a new content management system.

Welcome

Finfacts is Ireland's leading business information site and you are in its business news section.

We provide access to live business television and business related videos from: Bloomberg TV; The Wall Street Journal; CNBC and the Financial Times. Click image:

Links

Global Income Per Capita

Global Cost of Living

Irish Tax 2008

Climate Change Reports

Global News

Newspapers

Search Finfacts News Pages

Content Management by interactivetools.com.

News : Irish

Last Updated: Apr 24, 2009 - 5:31:05 PM

First Life Sciences Fund established under the Enterprise Ireland Seed and Venture Capital Scheme 2007-2012; €75 million raised
By Finfacts Team
Apr 30, 2008 - 4:09:04 AM

Email this article
Printer friendly page

The First Life Sciences Fund established under the Enterprise Ireland Seed and Venture Capital Scheme 2007-2012 has been promoted by former Elan executives who have raised €75 million in venture capital to invest in life sciences projects over the next five years.

Dr Manus Rogan, Aidan King and Dr Ena Prosser have launched Fountain Healthcare Partners, a Dublin-based group that plans to invest in the speciality pharmaceuticals, biotechnology, medical devices and diagnostics sectors.

Enterprise Ireland has contributed €21.75 million, while the National Pension Reserve Fund has invested €15 million.

The Fund will invest from €0.5m to €7m per company and will have an emphasis on the specialty pharmaceuticals, biotechnology, medical devices and diagnostics sectors.

Over 90% of the capital invested in the fund was sourced from institutional investors of which 75% are Irish based. Institutional investors include the European Investment Fund and the National Pension Reserve Fund. A select number of high net worth individual investors
also participated.

Commenting on the announcement Dr Manus Rogan, a founding partner at Fountain said: “We have been very pleased with the level and quality of investor participation in the first close. There was clear support for our investment strategy, and we significantly exceeded our original first close target. Fountain is now targeting €100 million in commitments at its final close”.

Commenting at the launch Frank Ryan CEO, Enterprise Ireland said: “The €75m Fountain Healthcare Partners Fund I is led by a highly skilled team with significant industry experience. The Fund will be a vital contributor to the development of a dynamic and commercially viable venture capital sector in Ireland. Furthermore, it complements Enterprise Ireland’s role in supporting the sustained growth and development of the indigenous life sciences sector: building on the already strong platform and linkages provided by the multinational base in Ireland”.

“The life science sector in Ireland has clearly lacked a dedicated fund of scale and expertise to accelerate the commercialisation of innovative products emerging from our indigenous companies. Our aim is to help fill that gap.” commented Aidan King, Fountain’s New York based partner.

Fountain Healthcare Partners Fund I, one of the largest emerging manager VC funds in the life science sector globally in the past 2 years, will nvest this capital over multiple funding rounds alongside international and domestic life science focused VC firms.

Fountain’s investment premise holds that the global life science sector dynamics are currently very favorable for smaller venture backed private companies. Fountain also maintains that the Irish life science industry is at a turning point and has been underserved from a VC perspective.

Related Articles

ComReg says 54% of Irish households have broadband

Boston Scientific to invest €50 million in Galway Research and Development facility

Enterprise Ireland has invested €275 million in the Third Level Research and Innovation system since 2000; Funded 18 start-up companies

The Irish Mind and the Knowledge Economy: Should we bank everything on fuzzy leprechaunic political dreams?

European Innovation 2008: Global Information Technology Report 2007-2008 puts Estonia ahead of Ireland for second year

IONA Technologies reports first quarter 2008 revenue growth of 6 percent to $16.4 million and a a loss of $5.1 million

Bank of Ireland and UCC’s Financial Services Innovation Centre in €500k Research Collaboration Project

Martin announces €16.4 million investment for new "ground breaking" Research Centre; Investment will establish a "truly unique world-class multidisciplinary" centre

Value of Irish M&A deals down but number of deals up in first quarter 2008 according to Ion Equity M&A Tracker Survey

Zamano reports 18% rise in after-tax profits for 2007

Irish Medical Device company Crospon secures additional €3m funding